Pediatric Early Phase-Clinical Trial Network (PEP-CTN) Institutions
The Pediatric Early Phase-Clinical Trial Network (PEP-CTN) is comprised of 21 premier Children’s Oncology Group (COG) pediatric core member sites in the U.S. and 21 non-core member sites in the U.S., Canada and Australia. All sites were selected through a peer review process. The PEP-CTN serves as a national and international model for new agent development in pediatric oncology. This dedicated consortium provides the necessary infrastructure for the conduct of pediatric early phase clinical trials and pharmacokinetic and biomarker studies.